(Q79217708)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17031510%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17031510%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1 reference

Ahmed M Abu El-Asrar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17031510%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Emad B Abboud

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17031510%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Hassan Aldibhi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17031510%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Abdulrahman Al-Arfaj

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17031510%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17031510%20AND%20SRC:MED&resulttype=core&format=json

International Ophthalmology

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17031510%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17031510%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17031510%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

83-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17031510%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10792-006-9006-9

20 December 2019

exact match

0 references

cites work

Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease

1 reference

12 December 2020

Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab

1 reference

12 December 2020

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

Novel approaches to Behçet's disease

1 reference

12 December 2020

Anti-TNF-alpha therapy for sight threatening uveitis

1 reference

12 December 2020

Cytokine production profile in patients with Behcet's disease treated with infliximab

1 reference

12 December 2020

Chemokines and gelatinases in the aqueous humor of patients with active uveitis

1 reference

12 December 2020

Induction of autoantibodies during prolonged treatment with infliximab

1 reference

12 December 2020

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 reference

12 December 2020

Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12

1 reference

12 December 2020

Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis

1 reference

12 December 2020

Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity

1 reference

12 December 2020

The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet's disease with ocular involvement

1 reference

12 December 2020

Uveitis in Behçet disease: an analysis of 880 patients.

1 reference

12 December 2020

Behçet's disease: a new target for anti-tumour necrosis factor treatment

1 reference

12 December 2020

Infliximab in the treatment of refractory posterior uveitis

1 reference

12 December 2020

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

1 reference

12 December 2020

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

1 reference

12 December 2020

Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

1 reference

12 December 2020

Infliximab in refractory uveitis due to Behçet's disease

1 reference

12 December 2020

Infliximab for chronic cystoid macular edema associated with uveitis

1 reference

12 December 2020

Anti-TNFα Therapy Modulates the Phenotype of Peripheral Blood CD4+T Cells in Patients with Posterior Segment Intraocular Inflammation

1 reference

12 December 2020

Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).

1 reference

12 December 2020

Infliximab in the treatment of posterior uveitis in Behçet's disease. Long term follow up in four patients

1 reference

12 December 2020

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

1 reference

12 December 2020